Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$58,928,576
-$16,705,100 QoQ
Shares Held
2,447,200
-9.1% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#154
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cullen Capital Management, LLC holds $1,067,869,600 across 8 Drug Manufacturers - General names. PFE ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
2,033,040 | $318,618,028 | |
| 2 | JNJ |
Johnson & Johnson
|
1,099,077 | $279,132,585 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,016,795 | $259,158,157 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,132,367 | $65,246,986 | |
| 5 | PFE |
Pfizer Inc
This page
|
2,447,200 | $58,928,576 | |
| 6 | NVO |
Novo Nordisk A S
|
1,224,955 | $58,724,342 | |
| 7 | SNY |
Sanofi
|
615,593 | $26,261,197 | |
| 8 | ABBV |
AbbVie Inc.
|
7,152 | $1,799,729 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,928,576 | 2,447,200 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $75,633,676 | 2,693,507 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $52,223,541 | 2,097,331 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $57,551,344 | 2,258,687 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $88,320,330 | 3,643,578 | Shares | Sole | 2025-09-30 | |
| 2025-03-31 | $119,688,979 | 4,723,322 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $126,664,301 | 4,774,380 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $122,386,507 | 4,228,974 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $107,914,495 | 3,856,844 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $124,825,910 | 4,498,231 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $74,230,523 | 2,578,344 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $132,039,885 | 3,980,702 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $149,271,754 | 4,069,568 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $165,916,464 | 4,066,580 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $156,135,453 | 3,047,140 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $174,378,480 | 3,984,883 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $192,672,647 | 3,674,855 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $192,085,803 | 3,710,369 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $216,205,551 | 3,661,398 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $205,561,563 | 4,779,390 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $193,878,575 | 4,950,934 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $166,445,945 | 4,594,147 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $42,249,008 | 1,147,759 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $42,832,344 | 1,167,095 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $47,164,828 | 1,442,348 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $56,249,023 | 1,723,318 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||